Sizing the constraint out loud: management quantifies how much business its own limits are costing right now
The model's full reasoning — Q4 2021 call → NOWe need to determine if management on the call sized a gap between what the company is doing and what it could be doing right now due to an internal limit. The question asks: does management volunteer a specific, quantified or explicitly sized statement about business the company is CURRENTLY NOT CAPTURING because of a limit inside the company, rather than because of a lack of demand? We need to look for management's own words that size a shortfall due to internal capacity, not external factors like microchip shortage (which is external supply constraint) or raw material costs. The internal limit could be production capacity, ability to deliver, etc. In the transcript, there are mentions of capacity constraints? Let's scan. John Fortson mentions: "We completed alternative fatty acid production and saw the first sales of our new ALTAVEG product. We continue to assess other feedstocks and expect commercial sales to grow this year." That's about future growth. Mike Smith mentions: "We also sold non-CTO based alternative fatty acids as well as alternative fatty acid derivatives in Q4. We remain excited about the additional alternative fatty acid capacity at our Crossett facility coming online in early Q2 of this year to support more substantial future sales growth." That's about future capacity. There is mention of "debottlenecking projects at our Performance Materials facilities" but no specific sizing. What about the microchip shortage? That is an external limit (shortage of chips) affecting auto production, which is not an internal limit. Management says "we estimate the full year impact of Ingevity -- to Ingevity of microchip-related production losses to be about $60 million to $70 million in revenue." That is a sized gap due to external shortage of chips, not internal capacity. The question specifically says: "The limit is internal and the demand is real and present." The microchip shortage is a shortage of an input the company buys (chips) - that's external. So that doesn't count. What about internal capacity? Is there any mention of the company not being able to produce enough due to its own capacity? For example, in Performance Chemicals, they talk about price increases and volume growth. No mention of turning away orders. In Performance Materials, they talk about auto production constraints due to chips, not their own capacity.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WHF | WhiteHorse Finance, Inc. | Q1 2022 | 2022-05-10 | B+ |
| AOSL | Alpha and Omega Semiconductor Limited | Q2 2018 | 2018-02-07 | B |
WHF · Q1 2022 → YESThe question is: Does management put a size on the gap between what the company is doing and what it could be doing right now? Specifically, a quantified statement about business not captured due to i...
AOSL · Q2 2018 → YESThe question is: Does management put a size on the gap between what the company is doing and what it could be doing right now? Specifically, a quantified statement about business they're currently not...
ESS · Q2 2018 → NOWe need to determine if management on this call sizes a gap between what the company is doing and what it could be doing right now due to an internal limit, with specific quantification. The question asks: "does management PUT A SIZE ON THE GAP BETWEEN WHAT THE COMPANY IS DOING AND WHAT IT COULD BE DOING RIGHT NOW — that is, does management volunteer a specific, quantified or explicitly sized statement about business the company is CURRENTLY NOT CAPTURING because of a limit inside the company, rather than because of a lack of demand?" We need to look for any instance where management quantifies a shortfall due to internal capacity, such as occupancy, supply, or ability to serve demand. The transcript discusses strong demand, occupancy strategy, supply constraints, etc. But we need to see if they size a gap. Key points: They talk about occupancy being lower intentionally to push rents. They mention that they are favoring market rents over occupancy, so they are deliberately leaving some occupancy on the table. But is that a "limit inside the company"? It's a strategic choice, not a capacity limit. They also discuss supply constraints in the market, but that's external. They talk about development yields compressing, but that's about new development. They mention that they have not acquired properties due to tight cap rates, but that's investment decisions. They talk about Prop 10 and rent control, but that's regulatory. They mention that they have a strong demand and job growth, but no specific sizing of unserved demand due to internal limits. They mention that they are pushing rents at slightly lower occupancy, which will benefit 2019. That is a trade-off, not a gap. They also mention that they have a preferred equity program with $398 million outstanding, but that's not about unserved demand. They talk about supply in Seattle being higher, but that's external. They mention that they have a strong balance sheet and liquidity. No where do they say "we could have rented X more units if we had them" or "we have Y demand that we can't serve because of our own capacity." They talk about occupancy being at 96.5% and they are intentionally lowering it to push rents. That is not a capacity limit; it's a pricing strategy. They also mention that they have a development pipeline, but that's future. Thus, no specific sizing of an internal limit causing unserved demand.